You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 152 No. 10, OCTOBER 1992 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL INVESTIGATIONS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (47)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Survival in a Cohort of Human Immunodeficiency Virus—Infected Tuberculosis Patients in New York City

Implications for the Expansion of the AIDS Case Definition

Rand Stoneburner, MD; Eddy Laroche, MD; Rebecca Prevots, PhD; Tejinder Singh, PhD; Steve Blum, PhD; Paul Terry, MPH; Sara Reatrice, PhD; Jack Adler, MD

Arch Intern Med. 1992;152(10):2033-2037.


Abstract

Background.—
The occurrence of pulmonary tuberculosis in human immunodeficiency virus (HIV)—infected persons is believed to represent a less severe stage of HIV-related disease with a more favorable prognosis than other acquired immunodeficiency syndrome (AIDS)—defining conditions; therefore, it has been excluded from the AIDS definition established by the Centers for Disease Control (Atlanta, Ga) criteria.

Methods.—
To determine the prognosis of patients with HIV-related tuberculosis, we assessed the clinical, immunologic, and HIV infection status of a cohort of male subjects aged 20 to 44 years who were hospitalized with tuberculosis but without AIDS in New York City hospitals from 1985 through 1986, and we determined their mortality through May 1991.

Results.—
The 58 patients who agreed to participate were largely (90%) nonwhite and had a high prevalence of pulmonary tuberculosis (90%) and HIV infection (53%). Patients who were HIV seropositive had significantly lower CD4 cell counts (median, 0.136x109/L; range, 0.013x109 to 2.314x109/L vs median, 0.765 x 109/L; range, 0.284 x 109 to 2.333x109/L), and, during the follow-up period, an 83% mortality rate that was 7.5 times higher than the 11% rate in seronegative subjects. Survival analyses revealed that for all HIV-seropositive subjects the probability of death at 30 months was 72% and the median survival was 21 months (95% confidence interval, 15.5 to 26.5 months), while for HIV-seropositive subjects with CD4 cell counts of 0.2x109/L or less, the probability of death at 30 months was 92% and the median survival was 15.75 months (95% confidence interval, 14.0 to 17.6 months).

Conclusion.—
The prognosis for patients with HIV-related pulmonary tuberculosis is poor, and those with CD4 cell counts of 0.2x109/L or less have survival patterns similar to that of patients with AIDS. We believe that these data support the expansion of the AIDS case definition to include persons with both pulmonary tuberculosis and severe HIV-related immunosuppression.

(Arch Intern Med. 1992;152:2033-2037)



Author Affiliations

From the New York City (NY) Department of Health (Drs Stoneburner, Laroche, Prevots, Singh, Blum, and Reatrice and Mr Terry); and the Tuberculosis Elimination Program, Mount Sinai Medical Center, New York, NY (Dr Adler).


Footnotes

Accepted for publication February 21, 1992.

Reprint requests to Disease Intervention Research, Box 6, 125 Worth St, New York, NY 10013 (c/o Dr Chiasson).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Rapid scale-up of antiretroviral therapy at primary care sites in Zambia: feasibility and early outcomes.
Stringer et al.
JAMA 2006;296:782-793.
ABSTRACT | FULL TEXT  

Evaluation of the status of tuberculosis as part of the clinical case definition of AIDS in India
Attili et al.
Postgrad. Med. J. 2005;81:404-408.
ABSTRACT | FULL TEXT  

Hospitalizations for Tuberculosis in the United States in 2000: Predictors of In-Hospital Mortality
Hansel et al.
Chest 2004;126:1079-1086.
ABSTRACT | FULL TEXT  

Patient mortality of active pulmonary tuberculosis requiring mechanical ventilation
Lee et al.
Eur Respir J 2003;22:141-147.
ABSTRACT | FULL TEXT  

Dysregulated Production of Interleukin-8 in Individuals Infected with Human Immunodeficiency Virus Type 1 and Mycobacterium tuberculosis
Meddows-Taylor et al.
Infect. Immun. 1999;67:1251-1260.
ABSTRACT | FULL TEXT  

Factors Related to In-hospital Deaths in Patients With Tuberculosis
Sacks and Pendle
Arch Intern Med 1998;158:1916-1922.
ABSTRACT | FULL TEXT  

The Incidence of AIDS-Defining Illnesses in 4883 Patients With Human Immunodeficiency Virus Infection
Mocroft et al.
Arch Intern Med 1998;158:491-497.
ABSTRACT | FULL TEXT  

The Relationship Between Delayed or Incomplete Treatment and All-Cause Mortality in Patients With Tuberculosis
Pablos-Mendez et al.
JAMA 1996;276:1223-1228.
ABSTRACT  

National Trends in the Concurrence of Tuberculosis and Acquired Immunodeficiency Syndrome
Burwen et al.
Arch Intern Med 1995;155:1281-1286.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1992 American Medical Association. All Rights Reserved.